Evaluation of 4β-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism–Based Pharmacometric Model

A Bayesian mechanism–based pharmacokinetic/pharmacodynamic model of cytochrome P450 3A4 (CYP3A4) activity was developed based on a clinical study of the effects of ketoconazole and rifampin on midazolam exposure and plasma 4β-hydroxycholesterol (4βHC) concentrations. Simulations from the model demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Leil, T A, Kasichayanula, S, Boulton, D W, LaCreta, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076805/
https://www.ncbi.nlm.nih.gov/pubmed/24964282
http://dx.doi.org/10.1038/psp.2014.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076805/
https://www.ncbi.nlm.nih.gov/pubmed/24964282
http://dx.doi.org/10.1038/psp.2014.18

Ejemplares similares